Literature DB >> 3244392

Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres.

J A Brock1, T C Cunnane.   

Abstract

1. The effects of bretylium and guanethidine on the nerve terminal impulse and transmitter release from sympathetic postganglionic nerve terminals in the guinea-pig vas deferens have been studied in vitro using focal extracellular recording. Excitatory junction currents (EJCs) were used as a measure of transmitter release. 2. Both bretylium and guanethidine altered the configuration of the nerve terminal impulse in a manner consistent with their being local anaesthetics. 3. Bretylium (1-3 microM) only completely inhibited transmitter release when impulse propagation in the sympathetic nerve terminal was blocked. 4. In contrast, guanethidine (1-10 microM) could block transmitter release with little effect on the configuration of the nerve terminal impulse. 5. The inhibitory effects of these agents on both the nerve terminal impulse and on transmitter release were reversed by the indirectly acting sympathomimetic agent, d-amphetamine (1-10 microM). 6. Using this technique the mechanisms of action of drugs known to modify the transmitter release in sympathetic nerve terminals can be more precisely determined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244392     DOI: 10.1007/bf00179321

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves.

Authors:  S B Ross; T Gosztonyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Electrical activity at the sympathetic neuroeffector junction in the guinea-pig vas deferens.

Authors:  J A Brock; T C Cunnane
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

3.  On the mechanism of the adrenergic nerve blocking action of bretylium.

Authors:  G Haeusler; W Haefely; A Huerlimann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

4.  Guanethidine after twenty years: a pharmacologist's perspective.

Authors:  R A Maxwell
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

5.  Relationship between the nerve action potential and transmitter release from sympathetic postganglionic nerve terminals.

Authors:  J A Brock; T C Cunnane
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

6.  Actions of alpha, beta-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for cotransmission.

Authors:  R J Allcorn; T C Cunnane; K Kirkpatrick
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

7.  Studies on the interactions of guanethidine and bretylium with noradrenaline stores.

Authors:  C C Chang; J C Chang; C Y Su
Journal:  Br J Pharmacol Chemother       Date:  1967-06

8.  Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters.

Authors:  P Sneddon; G Burnstock
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

9.  Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium.

Authors:  E T Abbs; M I Robertson
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

10.  Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery.

Authors:  D Ramme; J T Regenold; K Starke; R Busse; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

View more
  13 in total

1.  The non-adrenergic, non-cholinergic response counteracts changes in guinea-pig airway tone with and without sympathetic activation.

Authors:  A Lindén; A Ullman; B E Skoogh; C G Löfdahl
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

2.  Non-adrenergic, non-cholinergic neural activation stabilizes smooth-muscle tone independently of eicosanoid factors in guinea-pig isolated airways.

Authors:  A Lindén; A Ullman; C G Löfdahl; B E Skoogh
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.

Authors:  X F Figueroa; M I Poblete; M P Boric; V E Mendizábal; E Adler-Graschinsky; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

4.  Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.

Authors:  H Racchi; M J Irarrázabal; M Howard; S Morán; R Zalaquett; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Mediation of excitatory neurotransmission by the release of ATP and noradrenaline in sheep mesenteric lymphatic vessels.

Authors:  M A Hollywood; N G McHale
Journal:  J Physiol       Date:  1994-12-01       Impact factor: 5.182

6.  Non-adrenergic, non-cholinergic neural activation in guinea-pig bronchi: powerful and frequency-dependent stabilizing effect on tone.

Authors:  A Lindén; A Ullman; C G Löfdahl; B E Skoogh
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

7.  Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens.

Authors:  V Margaret Jackson; Tom C Cunnane
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

8.  The fade of the purinergic neurogenic contraction of the guinea-pig vas deferens: analysis of possible mechanisms.

Authors:  B Driessen; I von Kügelgen; R Bültmann; D B Elrick; T C Cunnane; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

9.  Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP.

Authors:  R J Evans; A Surprenant
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Bretylium abolishes neurotransmitter release without necessarily abolishing the nerve terminal action potential in sympathetic terminals.

Authors:  K L Brain; T C Cunnane
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.